Vir Biotechnology, Inc. Collaboration Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2025
Amendment No. 1 to Definitive Collaboration Agreement by and among Glaxo Wellcome UK Limited, GlaxoSmithKline Biologicals S.A., and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Preliminary Collaboration Agreement between Glaxo Wellcome UK Limited and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Letter Amendment to Collaboration and License Agreement between Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. (December 23, 2020)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Development and Manufacturing Collaboration Agreement between Vir Biotechnology, Inc. and WuXi Biologics (Hong Kong) Limited
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2020
Definitive Collaboration Agreement among Glaxo Wellcome UK Limited, Beecham S.A., and Vir Biotechnology, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Preliminary Collaboration Agreement between GlaxoSmithKline and Vir Biotechnology, Inc. (April 5, 2020)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Amendment No. 2 to Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to Collaboration and License Agreement between Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc.
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Collaboration, Option, and License Agreement between Vir Biotechnology, Inc., Brii Biosciences Limited, and Brii Biosciences Offshore Limited
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Amendment No. 6 to Sub-Licence and Collaboration Agreement between Humabs Biomed SA and MedImmune, LLC
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 5 to Sub-License and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Fourth Amendment to Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment No. 3 to Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment No. 2 to Sub-License and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Extension Notice and Research Funding Adjustment under Sub-License and Collaboration Agreement between MedImmune LLC and Humabs BioMed SA
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Sub-Licence and Collaboration Agreement between MedImmune, LLC and Humabs BioMed SA (March 20, 2012)
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019